A future treatment for Parkinson’s disease might use magnetism instead of a permanently implanted brain pacemaker.
Scientists have shown that microscopic magnetic plates placed inside the brains of mice can be activated from outside the head and improve Parkinson’s-like movement problems.
The experiment combines two simple ideas in an unusual way. Magnetic fields can pass through the skull, while nerve cells can react to tiny physical forces, so researchers designed particles that connect those two effects.
Parkinson’s disease is a long-term brain disorder that becomes more common with age. It occurs when cells that produce the chemical messenger dopamine are gradually lost, disrupting the brain circuits needed for smooth and controlled movement.
Many patients take medicines that increase dopamine activity, especially levodopa. These treatments can be very effective, but symptoms may become harder to control as the disease progresses.
For some patients, doctors can use deep brain stimulation. During this treatment, surgeons place electrodes in a specific brain region and connect them to a battery-powered device that sends electrical pulses into the brain.
One important target is the subthalamic nucleus, or STN. Changing activity in this small region can reduce movement symptoms, but reaching it requires brain surgery and carefully positioned electrodes.
Researchers from Germany, the Netherlands and Belgium wanted to know whether the same region could be controlled in a different way. Their method uses magnetic nanoplatelets that are far smaller than anything a person could see without specialized equipment.
The particles have magnetic properties that allow them to react when an outside magnetic field is switched on. Instead of producing electricity, they create extremely small mechanical forces in the tissue around them.
Those forces matter because nerve cells can sense physical changes. Their membranes contain channels that open when the membrane is pushed, stretched or deformed, allowing charged ions to move into the cell and alter its activity.
The researchers injected the nanoplatelets into the STN of mice with damage to dopamine-producing brain cells. This damage caused movement difficulties designed to model key motor features of Parkinson’s disease.
Placing the particles in exactly the right location was essential. The team used a highly precise method to guide the injection because stimulating the wrong brain circuit would not be expected to produce the desired movement effect.
The mice were then placed in a magnetic field. As the nanoplatelets reacted, the resulting tiny forces activated pressure-sensitive channels in nearby nerve cells and changed activity in the targeted brain region.
The animals showed a clear improvement in their movement difficulties after stimulation. The researchers said the benefit was roughly comparable with the effect expected from an implanted deep brain stimulation device in the experimental model.
A major question with any material placed in the brain is whether it causes inflammation or tissue damage. The particles remained in the mice for several months, and the researchers reported no signs of inflammation during that period.
The present method is not completely non-invasive because the particles still have to be injected into the brain. The team is therefore studying whether future versions could be delivered into the bloodstream and then cross the protective blood-brain barrier to reach their target.
Scientists are also considering wearable magnetic-field generators. A patient might eventually use something similar to a headband, although considerable engineering and medical testing would be needed before such a device could become realistic.
The research was published in 2026 in Advanced Science. The international project included Friedrich-Alexander-Universität Erlangen-Nürnberg, RWTH Aachen University, Maastricht University and KU Leuven.
One strength of the study is that it did more than show that magnetic particles can activate brain cells. The researchers demonstrated a meaningful improvement in movement in living animals and monitored the implanted material for months.
Still, the study cannot yet tell us whether this approach will work in people. Human Parkinson’s disease is much more complicated than an experimental mouse model, and injecting nanoparticles into the human brain would require extensive evidence about safety, placement and long-term effects.
The idea is therefore best viewed as a proof of concept rather than a replacement for today’s deep brain stimulation.
If future research can make particle delivery safer and show that magnetic control remains reliable over many years, the technology could eventually offer doctors a more flexible way to reach deep brain circuits without permanent electrodes.
If you care about brain health, please read studies that Vitamin B may slow down cognitive decline, and Mediterranean diet could help lower risk of Parkinson’s.
For more health information, please see recent studies about how wheat gluten might be influencing our brain health, and Olive oil: a daily dose for better brain health..
Source: Friedrich-Alexander-Universität Erlangen-Nürnberg.
